{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:18:45Z","timestamp":1764782325537,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["No.2018M643439"],"award-info":[{"award-number":["No.2018M643439"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41434-022-00355-0","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T02:02:49Z","timestamp":1657072969000},"page":"18-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0597-2960","authenticated-orcid":false,"given":"Jie","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7577-3345","authenticated-orcid":false,"given":"Yunyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4717-6890","authenticated-orcid":false,"given":"Tsai-Hua","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-8919","authenticated-orcid":false,"given":"Troy C.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-5216","authenticated-orcid":false,"given":"Lung-Ji","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"355_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-3-319-57193-5_14","volume":"15","author":"GV Raymond","year":"2017","unstructured":"Raymond GV. Leukodystrophy: basic and clinical. Adv Neurobiol. 2017;15:365\u201382.","journal-title":"Adv Neurobiol"},{"key":"355_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10571-015-0234-2","volume":"36","author":"M Deon","year":"2015","unstructured":"Deon M, Marchetti DP, Donida B, Wajner M, Vargas C. Oxidative stress in patients with X-linked adrenoleukodystrophy. Cell Mol Neurobiol. 2015;36:497\u2013512.","journal-title":"Cell Mol Neurobiol"},{"key":"355_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s10038-018-0537-5","volume":"64","author":"T Ohashi","year":"2018","unstructured":"Ohashi T. Gene therapy for lysosomal storage diseases and peroxisomal diseases. J Hum Genet. 2018;64:139\u201343.","journal-title":"J Hum Genet"},{"key":"355_CR4","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/01.jnen.0000190064.28559.a4","volume":"64","author":"JM Powers","year":"2005","unstructured":"Powers JM, Pei Z, Heinzer AK, Deering R, Moser AB, Moser HW, et al. Adreno-leukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol. 2005;64:1067\u201379.","journal-title":"J Neuropathol Exp Neurol"},{"key":"355_CR5","first-page":"1945","volume":"18","author":"MR Jia","year":"2019","unstructured":"Jia MR, Wu WZ, Li CM, Cai XH, Zhang L, Yan F, et al. Clinical characteristics and phenotype distribution in 10 chinese patients with X-linked adrenoleukodystrophy. Exp Ther Med. 2019;18:1945\u201352.","journal-title":"Exp Ther Med"},{"key":"355_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","volume":"1822","author":"S Kemp","year":"2012","unstructured":"Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta. 2012;1822:1465\u201374.","journal-title":"Biochim Biophys Acta"},{"key":"355_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1194\/jlr.M044586","volume":"55","author":"T Sassa","year":"2014","unstructured":"Sassa T, Wakashima T, Ohno Y, Kihara A. Lorenzo\u2019s oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid. J Lipid Res. 2014;55:524\u201330.","journal-title":"J Lipid Res"},{"key":"355_CR8","doi-asserted-by":"publisher","first-page":"102583","DOI":"10.1016\/j.transci.2019.06.019","volume":"59","author":"R Ciftciler","year":"2020","unstructured":"Ciftciler R, Goker H, Buyukasik Y, Topcu M, Gevher N, Demiroglu H. The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy. Transfus Apher Sci. 2020;59:102583.","journal-title":"Transfus Apher Sci"},{"key":"355_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11940-019-0605-y","volume":"21","author":"EJ Mallack","year":"2019","unstructured":"Mallack EJ, Turk B, Yan H, Eichler FS. The landscape of hematopoietic stem cell transplant and gene therapy for X-linked adrenoleukodystrophy. Curr Treat Options Neurol. 2019;21:61.","journal-title":"Curr Treat Options Neurol"},{"key":"355_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/gt.2014.103","volume":"22","author":"R Thwaite","year":"2014","unstructured":"Thwaite R, Pag\u00e8s G, Chill\u00f3n M, Bosch A. AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy. Gene Ther. 2014;22:196\u2013201.","journal-title":"Gene Ther"},{"key":"355_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","volume":"44","author":"L Zhao","year":"2016","unstructured":"Zhao L, Gottesdiener AJ, Parmar M, Li M, Kaminsky SM, Chiuchiolo MJ, et al. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer\u2019s disease mouse models. Neurobiol Aging. 2016;44:159\u201372.","journal-title":"Neurobiol Aging"},{"key":"355_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1474-4422(17)30169-2","volume":"16","author":"M Tardieu","year":"2017","unstructured":"Tardieu M, Z\u00e9rah M, Gougeon M-L, Ausseil J, de Bournonville S, Husson B, et al. Intracerebral gene therapy in children with mucopolysaccharidosis type IIIb syndrome: an uncontrolled phase 1\/2 clinical trial. Lancet Neurol. 2017;16:712\u201320.","journal-title":"Lancet Neurol"},{"key":"355_CR13","doi-asserted-by":"publisher","first-page":"e01096","DOI":"10.1002\/brb3.1096","volume":"8","author":"KN Russell","year":"2018","unstructured":"Russell KN, Mitchell NL, Anderson NG, Bunt CR, Wellby MP, Melzer TR, et al. Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses. Brain Behav. 2018;8:e01096.","journal-title":"Brain Behav"},{"key":"355_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S2352-4642(17)30125-6","volume":"1","author":"Y-H Chien","year":"2017","unstructured":"Chien Y-H, Lee N-C, Tseng S-H, Tai C-H, Muramatsu S-I, Byrne BJ, et al. Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1\/2 trial. Lancet Child Adoles Health. 2017;1:265\u201373.","journal-title":"Lancet Child Adoles Health"},{"key":"355_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL 3rd, Strohl WR. Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs. 2017;31:317\u201334.","journal-title":"BioDrugs"},{"key":"355_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.gt.3300895","volume":"6","author":"L-J Chang","year":"1999","unstructured":"Chang L-J, Urlacher V, Iwakuma T, Cui Y, Zucali J. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther. 1999;6:715\u201328.","journal-title":"Gene Ther"},{"key":"355_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1566523013348634","volume":"1","author":"L-J Chang","year":"2001","unstructured":"Chang L-J, Gay EE. The molecular genetics of lentiviral vectors - current and future perspectives. Curr Gene Ther. 2001;1:237\u201351.","journal-title":"Curr Gene Ther"},{"key":"355_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0486-0","volume":"14","author":"M Engelen","year":"2014","unstructured":"Engelen M, Kemp S, Poll-The BT. X-linked adrenoleukodystrophy: Pathogenesis and treatment. Curr Neurol Neurosci Rep. 2014;14:486.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"355_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler F, Duncan C, Musolino PL, Orchard PJ, De Oliveira S, Thrasher AJ, et al. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med. 2017;377:1630\u20138.","journal-title":"N Engl J Med"},{"key":"355_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"SH-B-A Nathalie Cartier","year":"2009","unstructured":"Nathalie Cartier SH-B-A. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009;326:818\u201323.","journal-title":"Science"},{"key":"355_CR21","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","volume":"383","author":"S Palfi","year":"2014","unstructured":"Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, et al. Long-term safety and tolerability of prosavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial. Lancet. 2014;383:1138\u201346.","journal-title":"Lancet"},{"key":"355_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.15252\/emmm.201505850","volume":"8","author":"V Meneghini","year":"2016","unstructured":"Meneghini V, Lattanzi A, Tiradani L, Bravo G, Morena F, Sanvito F, et al. Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe-affected non-human primates by intracerebral lentiviral gene therapy. EMBO Mol Med. 2016;8:489\u2013510.","journal-title":"EMBO Mol Med"},{"key":"355_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/sj.gt.3302509","volume":"12","author":"L-J Chang","year":"2005","unstructured":"Chang L-J, Liu X, He J. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Ther. 2005;12:1133\u201344.","journal-title":"Gene Ther"},{"key":"355_CR24","doi-asserted-by":"publisher","first-page":"101397","DOI":"10.1016\/j.jbc.2021.101397","volume":"297","author":"J Gong","year":"2021","unstructured":"Gong J, Chung T-H, Zheng J, Zheng H, Chang L-J. Transduction of modified factor VIII gene improves lentiviral gene therapy efficacy for hemophilia A. J Biol Chem. 2021;297:101397.","journal-title":"J Biol Chem"},{"key":"355_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-1759(94)00247-T","volume":"178","author":"SJ Vowells","year":"1995","unstructured":"Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Meth. 1995;178:89\u201397.","journal-title":"J Immunol Meth"},{"key":"355_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","volume":"11","author":"A Pujol","year":"2002","unstructured":"Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet. 2002;11:499\u2013505.","journal-title":"Hum Mol Genet"},{"key":"355_CR27","doi-asserted-by":"publisher","first-page":"9366","DOI":"10.1073\/pnas.94.17.9366","volume":"94","author":"JF Lu","year":"1997","unstructured":"Lu JF, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, et al. A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA. 1997;94:9366\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"355_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1006\/bbrc.1997.6340","volume":"232","author":"T Kobayashi","year":"1997","unstructured":"Kobayashi T, Shinnoh N, Kondo A, Yamada T. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Bioch and Biophys Res Comm. 1997;232:5.","journal-title":"Bioch and Biophys Res Comm"},{"key":"355_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jdn.10003","volume":"80","author":"BR Turk","year":"2020","unstructured":"Turk BR, Theda C, Fatemi A, Moser AB. X-linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci. 2020;80:52\u201372.","journal-title":"Int J Dev Neurosci"},{"key":"355_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1471-4159.1976.tb04462.x","volume":"26","author":"M Igarashi","year":"1976","unstructured":"Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, Kolodny E, Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976;26:851\u201360.","journal-title":"J Neurochem"},{"key":"355_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbadis.2003.10.004","volume":"1688","author":"CR Vargas","year":"2004","unstructured":"Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta. 2004;1688:26\u201332.","journal-title":"Biochim Biophys Acta"},{"key":"355_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1159\/000191212","volume":"30","author":"T Uto","year":"2008","unstructured":"Uto T, Contreras MA, Gilg AG, Singh I. Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts. Dev Neurosci. 2008;30:410\u20138.","journal-title":"Dev Neurosci"},{"key":"355_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0197-0186(03)00162-1","volume":"44","author":"A Di Biase","year":"2004","unstructured":"Di Biase A, Di Benedetto R, Fiorentini C, Travaglione S, Salvati S, Attorri L, et al. Free radical release in C6 glial cells enriched in hexacosanoic acid: Implication for X-linked adrenoleukodystrophy pathogenesis. Neurochem Int. 2004;44:215\u201321.","journal-title":"Neurochem Int"},{"key":"355_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1089\/hum.2016.087","volume":"27","author":"M Hocquemiller","year":"2016","unstructured":"Hocquemiller M, Giersch L, Audrain M, Parker S, Cartier N. Adeno-associated virus-based gene therapy for CNS diseases. Hum Gene Ther. 2016;27:478\u201396.","journal-title":"Hum Gene Ther"},{"key":"355_CR35","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ymthe.2018.01.010","volume":"26","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zheng S, Tecedor L, Davidson BL. Overcoming limitations inherent in sulfamidase to improve mucopolysaccharidosis IIIa gene therapy. Mol Ther. 2018;26:1118\u201326.","journal-title":"Mol Ther"},{"key":"355_CR36","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ymthe.2016.12.025","volume":"25","author":"H Fu","year":"2017","unstructured":"Fu H, Meadows AS, Ware T, Mohney RP, McCarty DM. Near-complete correction of profound metabolomic impairments corresponding to functional benefit in MPS IIIb mice after IV rAAV9-hNAGLU gene delivery. Mol Ther. 2017;25:792\u2013802.","journal-title":"Mol Ther"},{"key":"355_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1089\/hum.2013.238","volume":"25","author":"M Tardieu","year":"2014","unstructured":"Tardieu M, Zerah M, Husson B, de Bournonville S, Deiva K, Adamsbaum C, et al. Intracerebral administration of adeno-associated viral vector serotype rh.10 carrying human SGSH and SUMF1 cDNAs in children with mucopolysaccharidosis type IIIa disease: results of a phase I\/II trial. Hum Gene Ther. 2014;25:506\u201316.","journal-title":"Hum Gene Ther"},{"key":"355_CR38","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1523\/JNEUROSCI.2016-16.2016","volume":"36","author":"W Liu","year":"2016","unstructured":"Liu W, Zhao L, Blackman B, Parmar M, Wong MY, Woo T, et al. Vectored intracerebral immunization with the anti-Tau monoclonal antibody PHF1 markedly reduces Tau pathology in mutant Tau transgenic mice. J Neurosci. 2016;36:12425\u201335.","journal-title":"J Neurosci"},{"key":"355_CR39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/jgm.2816","volume":"16","author":"C McIntyre","year":"2014","unstructured":"McIntyre C, Derrick-Roberts ALK, Byers S, Anson DS. Correction of murine mucopolysaccharidosis type IIIa central nervous system pathology by intracerebroventricular lentiviral-mediated gene delivery. J Gene Med. 2014;16:374\u201387.","journal-title":"J Gene Med"},{"key":"355_CR40","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1093\/hmg\/ddu034","volume":"23","author":"A Lattanzi","year":"2014","unstructured":"Lattanzi A, Salvagno C, Maderna C, Benedicenti F, Morena F, Kulik W, et al. Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy. Hum Mol Genet. 2014;23:3250\u201368.","journal-title":"Hum Mol Genet"},{"key":"355_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2007.08.008","volume":"209","author":"RJ Mandel","year":"2008","unstructured":"Mandel RJ, Burger C, Snyder RO. Viral vectors for in vivo gene transfer in Parkinson\u2019s disease: Properties and clinical grade production. Exp Neurol. 2008;209:58\u201371.","journal-title":"Exp Neurol"},{"key":"355_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2016.02.013","volume":"120","author":"SR Choudhury","year":"2017","unstructured":"Choudhury SR, Hudry E, Maguire CA, Sena-Esteves M, Breakefield XO, Grandi P. Viral vectors for therapy of neurologic diseases. Neuropharmacology. 2017;120:63\u201380.","journal-title":"Neuropharmacology"},{"key":"355_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.nbd.2011.12.038","volume":"48","author":"K Low","year":"2012","unstructured":"Low K, Aebischer P. Use of viral vectors to create animal models for Parkinson\u2019s disease. Neurobiol Dis. 2012;48:189\u2013201.","journal-title":"Neurobiol Dis"},{"key":"355_CR44","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fphar.2019.00724","volume":"10","author":"S Ingusci","year":"2019","unstructured":"Ingusci S, Verlengia G, Soukupova M, Zucchini S, Simonato M. Gene therapy tools for brain diseases. Front Pharmacol. 2019;10:724.","journal-title":"Front Pharmacol"},{"key":"355_CR45","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/mt.2015.6","volume":"23","author":"Y Gong","year":"2015","unstructured":"Gong Y, Mu D, Prabhakar S, Moser A, Musolino P, Ren J, et al. Adenoassociated virus serotype 9-mediated gene therapy for X-linked adrenoleukodystrophy. Mol Ther. 2015;23:824\u201334.","journal-title":"Mol Ther"},{"key":"355_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12311-013-0511-x","volume":"13","author":"LF Koziol","year":"2014","unstructured":"Koziol LF, Budding D, Andreasen N, D\u2019Arrigo S, Bulgheroni S, Imamizu H, et al. Consensus paper: the cerebellum\u2019s role in movement and cognition. Cerebellum (London, England). 2014;13:151\u201377.","journal-title":"Cerebellum (London, England)"},{"key":"355_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000460818","volume":"17","author":"M Samson","year":"2017","unstructured":"Samson M, Claassen DO. Neurodegeneration and the cerebellum. Neurodegener Dis. 2017;17:155\u201365.","journal-title":"Neurodegener Dis"},{"key":"355_CR48","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/hmg\/ddu727","volume":"24","author":"A Ribera","year":"2015","unstructured":"Ribera A, Haurigot V, Garcia M, Marco S, Motas S, Villacampa P, et al. Biochemical, histological and functional correction of mucopolysaccharidosis type IIIb by intra-cerebrospinal fluid gene therapy. Hum Mol Genet. 2015;24:2078\u201395.","journal-title":"Hum Mol Genet"},{"key":"355_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2015.02.019","volume":"161","author":"BB Chu","year":"2015","unstructured":"Chu BB, Liao YC, Qi W, Xie C, Du X, Wang J, et al. Cholesterol transport through lysosome-peroxisome membrane contacts. Cell. 2015;161:291\u2013306.","journal-title":"Cell"},{"key":"355_CR50","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s13311-019-00735-2","volume":"16","author":"C Casasnovas","year":"2019","unstructured":"Casasnovas C, Ruiz M, Schluter A, Naudi A, Fourcade S, Veciana M, et al. Biomarker identification, safety, and efficacy of high-dose antioxidants for adrenomyeloneuropathy: A phase II pilot study. Neurotherapeutics. 2019;16:1167\u201382.","journal-title":"Neurotherapeutics"},{"key":"355_CR51","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1089\/hum.2018.079","volume":"30","author":"Y Gong","year":"2019","unstructured":"Gong Y, Berenson A, Laheji F, Gao G, Wang D, Ng C, et al. Intrathecal adeno-associated viral vector-mediated gene delivery for adrenomyeloneuropathy. Hum Gene Ther. 2019;30:544\u201355.","journal-title":"Hum Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00355-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T06:33:23Z","timestamp":1676529203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00355-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":51,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1038\/s41434-022-00355-0","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"type":"print","value":"0969-7128"},{"type":"electronic","value":"1476-5462"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"13 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}